BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37954945)

  • 1. Class III Antiarrhythmics and Periprocedural Torsades de Pointes.
    Font CM; Tran CT
    JACC Case Rep; 2023 Oct; 23():101998. PubMed ID: 37954945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methadone-induced Torsades de pointes.
    Russell L; Levine D
    R I Med J (2013); 2013 Jul; 96(8):20-1. PubMed ID: 23923121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.
    Makkar RR; Fromm BS; Steinman RT; Meissner MD; Lehmann MH
    JAMA; 1993 Dec; 270(21):2590-7. PubMed ID: 8230644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Torsades de pointes: electrophysiologic studies in patients without transient pharmacologic or metabolic abnormalities.
    Horowitz LN; Greenspan AM; Spielman SR; Josephson ME
    Circulation; 1981 May; 63(5):1120-8. PubMed ID: 7471373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient QT prolongation with torsades de pointes tachycardia after ablation of permanent junctional reciprocating tachycardia.
    Grimm W; Hoffmann J; Menz V; Maisch B
    J Cardiovasc Electrophysiol; 1999 Dec; 10(12):1631-5. PubMed ID: 10636193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and proarrhythmia with the use of d,l-sotalol for sustained ventricular tachyarrhythmias.
    Kühlkamp V; Mermi J; Mewis C; Seipel L
    J Cardiovasc Pharmacol; 1997 Mar; 29(3):373-81. PubMed ID: 9125676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bradycardia-Induced Torsades de Pointes in Atrioventricular Block.
    Bhattad PB; Jha A; Wholey R
    Cureus; 2023 Apr; 15(4):e37507. PubMed ID: 37193431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing torsades de pointes by careful cardiac monitoring in hospital settings.
    Sommargren CE; Drew BJ
    AACN Adv Crit Care; 2007; 18(3):285-93. PubMed ID: 18019519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac arrest caused by torsades de pointes tachycardia after successful atrial flutter radiofrequency catheter ablation.
    Mantziari AA; Vassilikos VP; Chatzizisis YS; Dakos G; Stavropoulos G; Paraskevaidis S; Styliadis IH
    Open Cardiovasc Med J; 2011; 5():1-3. PubMed ID: 21660252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive factors of ventricular fibrillation triggered by pause-dependent torsades de pointes associated with acquired long QT interval: role of QT dispersion and left ventricular function.
    Da Costa A; Chalvidan T; Belounas A; Messier M; Viallet M; Mansour H; Lamaison D; Djiane P; Isaaz K
    J Cardiovasc Electrophysiol; 2000 Sep; 11(9):990-7. PubMed ID: 11021469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-related torsades de pointes in the isolated rabbit heart: comparison of clofilium, d,l-sotalol, and erythromycin.
    Eckardt L; Haverkamp W; Mertens H; Johna R; Clague JR; Borggrefe M; Breithardt G
    J Cardiovasc Pharmacol; 1998 Sep; 32(3):425-34. PubMed ID: 9733356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Torsades de pointes associated with remdesivir treatment for COVID-19 pneumonia.
    Fung JS; Levitan M; Landry S; McIsaac S
    J Assoc Med Microbiol Infect Dis Can; 2023 Mar; 8(1):99-104. PubMed ID: 37008584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case of Bradycardia-Induced Torsades De Pointes in a Patient Presenting to the Emergency Room With Cardiac Arrest.
    Mahanta D; Barik R; Budhia AK; Das D; Acharya D
    Cureus; 2023 Oct; 15(10):e46831. PubMed ID: 37954743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, therapeutic response, and outcome of ventricular tachycardia in the out-of-hospital setting: a comparison of monomorphic ventricular tachycardia, polymorphic ventricular tachycardia, and torsades de pointes.
    Brady WJ; DeBehnke DJ; Laundrie D
    Acad Emerg Med; 1999 Jun; 6(6):609-17. PubMed ID: 10386678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A practical approach to torsade de pointes.
    Roden DM
    Clin Cardiol; 1997 Mar; 20(3):285-90. PubMed ID: 9068917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cesium-induced atrial tachycardia degenerating into atrial fibrillation in dogs: atrial torsades de pointes?
    Satoh T; Zipes DP
    J Cardiovasc Electrophysiol; 1998 Sep; 9(9):970-5. PubMed ID: 9786077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrocardiographic measures of repolarization heterogeneity are not predictive for Torsades de Pointes among undifferentiated patients with prolonged QTc: A case control study.
    Marill KA; Lopez S; Hark D; Spahr J; Shesh-Muthal K; Xue J; Rowlandson GI; Liu SW
    J Cardiovasc Electrophysiol; 2023 Jan; 34(1):166-176. PubMed ID: 36335640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased ventricular ectopy precedes Torsades de Pointes in patients with prolonged QT.
    Marill KA; Lopez S; Hark D; Spahr J; Kapadia N; Liu SW
    J Electrocardiol; 2023; 80():17-23. PubMed ID: 37105125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent torsades de pointes after catheter ablation of incessant ventricular bigeminy in combination with QT prolongation.
    Reithmann C; Fiek M; Beckmann BM; Kääb S
    Europace; 2012 Feb; 14(2):299-300. PubMed ID: 21908450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypocalcemia Presenting as Life Threatening Torsades de Pointes with Prolongation of QTc Interval.
    Chhabra ST; Mehta S; Chhabra S; Singla M; Aslam N; Mohan B; Wander GS
    Indian J Clin Biochem; 2018 Apr; 33(2):235-238. PubMed ID: 29651218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.